| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/23/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 371 | $12.15 | $4.5k | | 03/21/2023 |
| 03/22/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 357 | $12.64 | $4.5k | | 03/21/2023 |
| 03/21/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 350 | $12.89 | $4.5k | | 03/21/2023 |
| 03/20/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 357 | $12.61 | $4.5k | | 03/17/2023 |
| 03/17/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 339 | $13.28 | $4.5k | | 03/17/2023 |
| 03/16/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 337 | $13.43 | $4.5k | | 03/15/2023 |
| 03/15/2023 | Tarsus Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 4.8k | $0.00 | $0 | | 03/15/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 42.8k | $15.00 | $642k | | 03/08/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 29k | $0.00 | $0 | | 03/08/2023 |
| 12/02/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 1.2k | $16.90 | $19.5k | | 12/02/2022 |
| 12/01/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 1.2k | $16.75 | $19.5k | | 11/29/2022 |
| 11/30/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 1.2k | $16.50 | $19.5k | | 11/29/2022 |
| 11/29/2022 | Tarsus Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 10.3k | $0.00 | $0 | | 11/29/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 65.3k | $19.59 | $1.3M | | 03/09/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 19.2k | $0.00 | $0 | | 03/09/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 34.2k | $0.00 | $0 | | 03/09/2022 |
| 02/02/2021 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 89.4k | $37.44 | $3.3M | | 02/02/2021 |